SLC7A11 acts as an oncogene and therapeutic target in various cancers.17,18 Results of a previous study demonstrated that Erastin- or imidazole ketone erastin-mediated SLC7A11 deficiency induced cell ferroptosis. The gene discussed is SLC7A11; the disease is cancer.